Nordic Educational Meeting on CLL, Stockholm, 19-20 April 2018
Live streaming can be followed via this link
From Monday April 23 at 3 pm will the recordings be accessible on demand from this website as well.
Questions may be asked during the live streaming of each session – only in real time – per e-mail email@example.com to the chairs.
Questions will only be answered if the topic is raised by the chair.
Plan for transmissions from the conference:
Thursday 19 April
10.30-10.40 Welcome address: Carsten Niemann on behalf of the organizing committee
Chairs: Rebecca Valentin & Carsten Niemann
10.40-11.20 Paolo Ghia: CLL – a complex disease
11.20-12.00 Carsten Niemann & Anders Österborg: State of the art in treatment of CLL
12.00-12.40 Susan O’Brien: New drugs in the pipeline
Chairs: Eva Kimby & Richard Rosenquist
14.00-14.40 Elias Campo: The genomic landscape of CLL: have we got lost?
Chairs: Marzia Palma & Hoa Tran
16.50-17.30 Jennifer Brown: Incorporation of microenvironmental findings into design of new clinical trials
18.30-19.10 Jennifer Woyach: Mutations and resistance to small therapeutic molecules; a growing clinical problem onwards
Friday 20 April
Chairs: Lesley-Ann Sutton & Anders Österborg
08.30-09.10 Davide Rossi & Richard Rosenquist: How to identify high-risk patients?
09.10-09.40 Edvard Smith: The History of Bruton’s Tyrosine Kinase
09.40-10.20 Peter Hillmen: How to treat high-risk patients
Chairs: Caspar da Cunha-Bang & Lotta Hansson
13.30-14.20 Real real-world /Registry-based studies. Lotta Hansson, Caspar da Cunha-Bang, Andrea Lenartova & Vesa Lindström
14.20-14.45 Nordic CLL Group: planned and future activites (discussion led by Carsten Niemann & Anders Österborg)
14.45-15.30 Michael Hallek: The future of therapy of chronic lymphocytic leukemia
The meeting has been supported by an unrestricted grant from Gilead Sciences
and by an educational grant from the following sponsors:
Reimbursement for participants:
OBS! Because of different rules for reimbursement of costs between the Nordic countries there is only this form which applies to participants from DENMARK, FINLAND, ICELAND, BALTICS: